Literature DB >> 24643537

Clostridium perfringens type A enterotoxin damages the rabbit colon.

Jorge P Garcia1, Jihong Li, Archana Shrestha, John C Freedman, Juliann Beingesser, Bruce A McClane, Francisco A Uzal.   

Abstract

Clostridium perfringens enterotoxin causes the gastrointestinal (GI) symptoms of C. perfringens type A food poisoning and CPE-associated non-food-borne human GI diseases. It is well established that CPE induces fluid accumulation and severe tissue damage in ligated small intestinal loops of rabbits and other animals. However, a previous study had also reported that CPE binds to rabbit colonic cells yet does not significantly affect rabbit colonic loops. To the contrary, the current study determined that treatment with 50 or 100 μg/ml of CPE causes significant histologic lesions and luminal fluid accumulation in rabbit colonic loops. Interestingly, a CPE-neutralizing monoclonal antibody blocked the development of CPE-induced histologic damage but not luminal fluid accumulation in these loops. Similar luminal fluid accumulation, without significant histologic damage, also occurred after treatment of colonic loops with heat-inactivated CPE, antibody alone, or bovine serum albumin (BSA), indicating that increased osmolarity was causing or contributing to fluid accumulation in CPE-treated colonic loops. Comparative studies revealed the similar development of histologic damage and luminal fluid accumulation in both small intestinal loops and colonic loops after as little as a 1-h treatment with 50 μg/ml of CPE. Consistent with the CPE sensitivity of the small intestine and colon, Western blotting detected CPE binding and large-complex formation in both organs. In addition, Western blotting demonstrated the presence of the high-affinity CPE receptors claudin-3 and -4 in both organs of rabbits, consistent with the observed toxin binding. Collectively, these results offer support for the possible involvement of the colon in CPE-mediated GI disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24643537      PMCID: PMC4019184          DOI: 10.1128/IAI.01659-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Clostridium perfringens enterotoxin damages the human intestine in vitro.

Authors:  M E Fernández Miyakawa; V Pistone Creydt; F A Uzal; B A McClane; C Ibarra
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  Evaluation of ELISA, RPLA, and Vero cell assays for detecting Clostridium perfringens enterotoxin in faecal specimens.

Authors:  P R Berry; J C Rodhouse; S Hughes; B A Bartholomew; R J Gilbert
Journal:  J Clin Pathol       Date:  1988-04       Impact factor: 3.411

3.  Production, purification, and assay of Clostridium perfringens enterotoxin.

Authors:  J L McDonel; B A McClane
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

4.  Identification of a prepore large-complex stage in the mechanism of action of Clostridium perfringens enterotoxin.

Authors:  James G Smedley; Francisco A Uzal; Bruce A McClane
Journal:  Infect Immun       Date:  2007-02-16       Impact factor: 3.441

5.  Cysteine-scanning mutagenesis supports the importance of Clostridium perfringens enterotoxin amino acids 80 to 106 for membrane insertion and pore formation.

Authors:  Jianwu Chen; James R Theoret; Archana Shrestha; James G Smedley; Bruce A McClane
Journal:  Infect Immun       Date:  2012-09-10       Impact factor: 3.441

6.  Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis.

Authors:  Rudolf Mennigen; Kerstin Nolte; Emile Rijcken; Markus Utech; Bettina Loeffler; Norbert Senninger; Matthias Bruewer
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-02-12       Impact factor: 4.052

7.  Clostridium perfringens type A enterotoxin induces tissue damage and fluid accumulation in rabbit ileum.

Authors:  S Sherman; E Klein; B A McClane
Journal:  J Diarrhoeal Dis Res       Date:  1994-09

8.  Foodborne illness acquired in the United States--major pathogens.

Authors:  Elaine Scallan; Robert M Hoekstra; Frederick J Angulo; Robert V Tauxe; Marc-Alain Widdowson; Sharon L Roy; Jeffery L Jones; Patricia M Griffin
Journal:  Emerg Infect Dis       Date:  2011-01       Impact factor: 6.883

9.  Molecular cloning and functional characterization of the receptor for Clostridium perfringens enterotoxin.

Authors:  J Katahira; N Inoue; Y Horiguchi; M Matsuda; N Sugimoto
Journal:  J Cell Biol       Date:  1997-03-24       Impact factor: 10.539

Review 10.  Claudins in intestines: Distribution and functional significance in health and diseases.

Authors:  Zhe Lu; Lei Ding; Qun Lu; Yan-Hua Chen
Journal:  Tissue Barriers       Date:  2013-05-30
View more
  12 in total

1.  Native or Proteolytically Activated NanI Sialidase Enhances the Binding and Cytotoxic Activity of Clostridium perfringens Enterotoxin and Beta Toxin.

Authors:  James R Theoret; Jihong Li; Mauricio A Navarro; Jorge P Garcia; Francisco A Uzal; Bruce A McClane
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

Review 2.  Targeting and alteration of tight junctions by bacteria and their virulence factors such as Clostridium perfringens enterotoxin.

Authors:  Miriam Eichner; Jonas Protze; Anna Piontek; Gerd Krause; Jörg Piontek
Journal:  Pflugers Arch       Date:  2016-11-18       Impact factor: 3.657

3.  CodY Promotes Sporulation and Enterotoxin Production by Clostridium perfringens Type A Strain SM101.

Authors:  Jihong Li; John C Freedman; Daniel R Evans; Bruce A McClane
Journal:  Infect Immun       Date:  2017-02-23       Impact factor: 3.441

Review 4.  Clostridium perfringens type A-E toxin plasmids.

Authors:  John C Freedman; James R Theoret; Jessica A Wisniewski; Francisco A Uzal; Julian I Rood; Bruce A McClane
Journal:  Res Microbiol       Date:  2014-10-02       Impact factor: 3.992

5.  Duodenitis-Proximal Jejunitis in Horses After Experimental Administration of Clostridium difficile Toxins.

Authors:  L G Arroyo; M C Costa; B B Guest; B L Plattner; B N Lillie; J S Weese
Journal:  J Vet Intern Med       Date:  2016-12-01       Impact factor: 3.333

6.  Effect of Clostridium perfringens enterotoxin on gastric cancer cells SGC7901 which highly expressed claudin-4 protein.

Authors:  Zheng-Yun Liang; Xing Kang; Hong Chen; Meng Wang; Wen-Xian Guan
Journal:  World J Gastrointest Oncol       Date:  2017-04-15

Review 7.  Mechanisms of Action and Cell Death Associated with Clostridium perfringens Toxins.

Authors:  Mauricio A Navarro; Bruce A McClane; Francisco A Uzal
Journal:  Toxins (Basel)       Date:  2018-05-22       Impact factor: 4.546

8.  Clostridium perfringens Enterotoxin: The Toxin Forms Highly Cation-Selective Channels in Lipid Bilayers.

Authors:  Roland Benz; Michel R Popoff
Journal:  Toxins (Basel)       Date:  2018-08-22       Impact factor: 4.546

Review 9.  Clostridium perfringens Enterotoxin: Action, Genetics, and Translational Applications.

Authors:  John C Freedman; Archana Shrestha; Bruce A McClane
Journal:  Toxins (Basel)       Date:  2016-03-16       Impact factor: 4.546

10.  Development of Adjuvant-Free Bivalent Food Poisoning Vaccine by Augmenting the Antigenicity of Clostridium perfringens Enterotoxin.

Authors:  Hidehiko Suzuki; Koji Hosomi; Ayaka Nasu; Masuo Kondoh; Jun Kunisawa
Journal:  Front Immunol       Date:  2018-10-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.